Netpharmalab updates its visual identity to reflect its growth, expanded capabilities, the integration of Docuchem and its consolidation as part of AGQ Labs Group
Netpharmalab is entering a new chapter with the launch of its new visual identity. This evolution reflects the company’s growth in recent years and its firm commitment to continuing to provide high-value analytical solutions for the pharmaceutical and biotechnology industries and research institutions.
During this period, the company has significantly expanded its technical capabilities, introduced new specialised services and strengthened its team through the integration of Docuchem, creating a stronger organisation that is better prepared to meet the sector’s current and future challenges.
As a result of this evolution, Netpharmalab now has two operational sites, located in Madrid and Catalonia, from which it provides broader coverage, greater technical capacity and a more responsive service for its clients.
This new chapter is also marked by a strong commitment to high-growth strategic areas, such as analytical services for biological medicines, biosimilars and advanced therapies. This further strengthens Netpharmalab’s position as a laboratory specialising in the development and quality control of new generations of pharmaceutical products.
The new visual identity represents this evolution. The company has adopted a more modern image that reinforces its position as part of an international group with extensive experience in analytical and inspection services across multiple sectors.
This rebrand does not change the essence of the company. Instead, it reflects a new reality: an organisation with greater capabilities, a broader range of services and a multidisciplinary team that brings together the knowledge, experience and talent of all the professionals involved in the project.
Our new identity reflects who we are today: a stronger company with greater capabilities, ready to support our clients in addressing the scientific and regulatory challenges facing the pharmaceutical and biotechnology industries.
Through this evolution, Netpharmalab reaffirms its commitment to scientific excellence, quality, innovation and close client relationships, further consolidating its position as a leading analytical partner for the development, characterisation and quality control of medicines, biological products and advanced therapies.
The new identity will be progressively introduced across all the company’s communication channels, technical documentation and corporate materials, symbolising a new phase of growth focused on continuing to create value for clients, partners and industry professionals.
